Regenative Labs Updates Wharton’s Jelly Knee Study
Feb 20, 2023
New data demonstrates statistically significant reported WOMAC improvement. February 20, 2023, Pensacola, FL – Regenative Labs (Regenative), a leading HCT/P… Read More >
Regenative Labs & Dr. Albert Lai: Wharton’s Jelly in Si Joint Care
Jan 19, 2023
January 19, 2023. Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer, announces a retrospective analysis of patients who have… Read More >
Regenative Labs: Wharton’s Jelly in Post-Surgical Breast Care
Jan 09, 2023
January 9, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading HCT/P manufacturer has published a case study in the Journal… Read More >
Advances through Value-Based Outcomes
Nov 30, 2022
This month marks five years since the FDA HCT/P regulations were first introduced. In that time we have (1) produced… Read More >
Research, Not Rebates
Nov 22, 2022
We know physicians drive innovation in medicine, and we are dedicated to our data-driven, outcomes-focused approach to advance this field… Read More >